Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 14 | 2023 | 1052 | 1.370 |
Why?
|
| Heart Ventricles | 7 | 2023 | 762 | 1.100 |
Why?
|
| Calcinosis | 3 | 2012 | 176 | 0.870 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 2 | 2012 | 43 | 0.750 |
Why?
|
| Emergency Medicine | 1 | 2022 | 154 | 0.670 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 172 | 0.650 |
Why?
|
| Echocardiography, Transesophageal | 8 | 2013 | 240 | 0.630 |
Why?
|
| Heart Aneurysm | 2 | 2012 | 38 | 0.620 |
Why?
|
| Mitral Valve | 5 | 2012 | 248 | 0.600 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2013 | 143 | 0.560 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2012 | 155 | 0.530 |
Why?
|
| Heart Failure | 6 | 2012 | 2285 | 0.500 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2014 | 18 | 0.450 |
Why?
|
| Systole | 4 | 2023 | 198 | 0.440 |
Why?
|
| Incidental Findings | 2 | 2012 | 126 | 0.430 |
Why?
|
| Thrombosis | 3 | 2012 | 521 | 0.410 |
Why?
|
| Sinus of Valsalva | 1 | 2013 | 35 | 0.400 |
Why?
|
| Pericardium | 1 | 2013 | 81 | 0.390 |
Why?
|
| Heart-Assist Devices | 3 | 2012 | 1021 | 0.390 |
Why?
|
| Ablation Techniques | 1 | 2012 | 31 | 0.380 |
Why?
|
| Aortic Rupture | 1 | 2013 | 120 | 0.370 |
Why?
|
| Ethanol | 1 | 2012 | 163 | 0.350 |
Why?
|
| Heart Valve Prosthesis Implantation | 3 | 2020 | 436 | 0.350 |
Why?
|
| Echocardiography, Doppler, Color | 4 | 2013 | 112 | 0.330 |
Why?
|
| Diagnostic Imaging | 4 | 2014 | 276 | 0.330 |
Why?
|
| Quality Assurance, Health Care | 4 | 2013 | 206 | 0.320 |
Why?
|
| Myocardial Ischemia | 3 | 2014 | 340 | 0.320 |
Why?
|
| Fluorocarbons | 2 | 2008 | 55 | 0.300 |
Why?
|
| Methemoglobinemia | 1 | 2008 | 8 | 0.290 |
Why?
|
| Pericarditis, Constrictive | 1 | 2008 | 4 | 0.290 |
Why?
|
| Mitral Valve Stenosis | 1 | 2008 | 34 | 0.290 |
Why?
|
| Palliative Care | 1 | 2012 | 428 | 0.290 |
Why?
|
| Cardiac Tamponade | 1 | 2008 | 36 | 0.290 |
Why?
|
| Tricuspid Valve | 1 | 2008 | 60 | 0.280 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 65 | 0.280 |
Why?
|
| Cardiology | 4 | 2014 | 504 | 0.280 |
Why?
|
| Thoracic Injuries | 1 | 2008 | 90 | 0.280 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2008 | 63 | 0.280 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2008 | 74 | 0.270 |
Why?
|
| Cor Triatriatum | 1 | 2007 | 10 | 0.270 |
Why?
|
| Hematoma | 1 | 2008 | 93 | 0.270 |
Why?
|
| Contrast Media | 2 | 2012 | 473 | 0.250 |
Why?
|
| Ventricular Function, Left | 4 | 2016 | 506 | 0.250 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 215 | 0.250 |
Why?
|
| Humans | 39 | 2023 | 124703 | 0.240 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2006 | 133 | 0.230 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 491 | 0.230 |
Why?
|
| Albumins | 1 | 2005 | 89 | 0.230 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 1116 | 0.220 |
Why?
|
| Heart Neoplasms | 1 | 2005 | 101 | 0.220 |
Why?
|
| Heart Septum | 1 | 2003 | 54 | 0.220 |
Why?
|
| Ventricular Function, Right | 2 | 2022 | 110 | 0.210 |
Why?
|
| Aortic Valve | 2 | 2020 | 443 | 0.210 |
Why?
|
| American Heart Association | 3 | 2014 | 322 | 0.200 |
Why?
|
| Heart Valve Prosthesis | 3 | 2004 | 301 | 0.200 |
Why?
|
| Sarcoma | 1 | 2005 | 183 | 0.200 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2012 | 366 | 0.200 |
Why?
|
| Advisory Committees | 2 | 2013 | 153 | 0.190 |
Why?
|
| Ultrasonography | 3 | 2022 | 929 | 0.190 |
Why?
|
| Cardiovascular Diseases | 5 | 2013 | 1952 | 0.180 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2002 | 155 | 0.180 |
Why?
|
| Male | 20 | 2017 | 61264 | 0.180 |
Why?
|
| Thrombolytic Therapy | 2 | 2004 | 212 | 0.180 |
Why?
|
| Echocardiography, Doppler | 3 | 2010 | 171 | 0.170 |
Why?
|
| Guideline Adherence | 2 | 2013 | 382 | 0.170 |
Why?
|
| Adult | 14 | 2014 | 29481 | 0.170 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 2155 | 0.170 |
Why?
|
| Exercise Test | 1 | 2001 | 254 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2001 | 173 | 0.160 |
Why?
|
| Diastole | 1 | 1999 | 170 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 5 | 2013 | 1269 | 0.150 |
Why?
|
| Echocardiography, Stress | 2 | 2008 | 15 | 0.150 |
Why?
|
| Plasminogen Activators | 1 | 1998 | 20 | 0.150 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1998 | 40 | 0.150 |
Why?
|
| Heart | 1 | 2022 | 710 | 0.150 |
Why?
|
| Female | 17 | 2014 | 66557 | 0.150 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2020 | 199 | 0.140 |
Why?
|
| Nebivolol | 1 | 2016 | 4 | 0.140 |
Why?
|
| Vagus Nerve | 1 | 2017 | 44 | 0.140 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2016 | 13 | 0.140 |
Why?
|
| Prosthesis Failure | 1 | 1998 | 158 | 0.130 |
Why?
|
| Heart Diseases | 3 | 2010 | 491 | 0.130 |
Why?
|
| Metoprolol | 1 | 2016 | 22 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2020 | 12354 | 0.130 |
Why?
|
| Hemodynamics | 3 | 2013 | 848 | 0.130 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 334 | 0.130 |
Why?
|
| Defibrillators, Implantable | 2 | 2013 | 190 | 0.130 |
Why?
|
| Microspheres | 2 | 2008 | 70 | 0.130 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 2 | 2013 | 21 | 0.130 |
Why?
|
| Heart Conduction System | 1 | 2017 | 146 | 0.130 |
Why?
|
| Electrocardiography | 3 | 2014 | 975 | 0.130 |
Why?
|
| Botulinum Toxins | 1 | 2017 | 119 | 0.120 |
Why?
|
| Middle Aged | 11 | 2014 | 26796 | 0.120 |
Why?
|
| Tachycardia, Ventricular | 1 | 2016 | 192 | 0.110 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 29 | 0.100 |
Why?
|
| Biomedical Technology | 1 | 2013 | 36 | 0.100 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2013 | 53 | 0.100 |
Why?
|
| Risk Assessment | 5 | 2014 | 3447 | 0.100 |
Why?
|
| Anticoagulants | 2 | 2012 | 592 | 0.090 |
Why?
|
| Coronary Angiography | 1 | 2014 | 441 | 0.090 |
Why?
|
| Heart Rate | 1 | 2014 | 590 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2008 | 5160 | 0.090 |
Why?
|
| Laboratories, Hospital | 1 | 2011 | 20 | 0.090 |
Why?
|
| Cardiovascular Agents | 1 | 2012 | 88 | 0.090 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1883 | 0.090 |
Why?
|
| Sex Factors | 1 | 2014 | 1286 | 0.090 |
Why?
|
| Aspirin | 1 | 2012 | 223 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 659 | 0.080 |
Why?
|
| United States | 8 | 2014 | 10897 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3556 | 0.080 |
Why?
|
| Prosthesis Design | 3 | 2010 | 679 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1163 | 0.070 |
Why?
|
| Pericardiectomy | 1 | 2008 | 10 | 0.070 |
Why?
|
| Cytochrome-B(5) Reductase | 1 | 2008 | 4 | 0.070 |
Why?
|
| Cyanosis | 1 | 2008 | 42 | 0.070 |
Why?
|
| Age Factors | 1 | 2014 | 2819 | 0.070 |
Why?
|
| Aged | 7 | 2014 | 19763 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2020 | 16325 | 0.070 |
Why?
|
| Risk Factors | 3 | 2020 | 10284 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2008 | 356 | 0.070 |
Why?
|
| Oximetry | 1 | 2008 | 162 | 0.070 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 183 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 177 | 0.060 |
Why?
|
| Coronary Disease | 3 | 2008 | 674 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 254 | 0.060 |
Why?
|
| Anesthetics, Dissociative | 1 | 2004 | 20 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2012 | 6548 | 0.050 |
Why?
|
| Death, Sudden | 1 | 2003 | 45 | 0.050 |
Why?
|
| Prosthesis Implantation | 1 | 2005 | 141 | 0.050 |
Why?
|
| Radiography | 1 | 2006 | 821 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2005 | 440 | 0.050 |
Why?
|
| Utilization Review | 2 | 2013 | 40 | 0.050 |
Why?
|
| Decision Making | 3 | 2014 | 655 | 0.050 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2002 | 30 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 243 | 0.050 |
Why?
|
| Organ Size | 1 | 2022 | 425 | 0.050 |
Why?
|
| Health Services Research | 2 | 2013 | 188 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2007 | 729 | 0.050 |
Why?
|
| Video Recording | 1 | 2002 | 182 | 0.040 |
Why?
|
| Ketamine | 1 | 2004 | 216 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 1233 | 0.040 |
Why?
|
| Patient Safety | 2 | 2014 | 399 | 0.040 |
Why?
|
| Internet | 1 | 2002 | 375 | 0.040 |
Why?
|
| Dobutamine | 1 | 1999 | 56 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2005 | 855 | 0.040 |
Why?
|
| Disease Progression | 1 | 2003 | 2049 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2020 | 385 | 0.030 |
Why?
|
| Algorithms | 2 | 2014 | 1622 | 0.030 |
Why?
|
| Sheep | 1 | 2017 | 219 | 0.030 |
Why?
|
| Warfarin | 1 | 1998 | 119 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 125 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1998 | 550 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2016 | 181 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2016 | 118 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 1995 | 25 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 431 | 0.030 |
Why?
|
| Prognosis | 3 | 1999 | 4626 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2016 | 488 | 0.030 |
Why?
|
| Mutation | 1 | 2008 | 5825 | 0.030 |
Why?
|
| Hypotension | 1 | 1995 | 185 | 0.030 |
Why?
|
| Coronary Occlusion | 1 | 2013 | 29 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2013 | 135 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1688 | 0.030 |
Why?
|
| Vascular Calcification | 1 | 2013 | 56 | 0.030 |
Why?
|
| Cattle | 2 | 2004 | 564 | 0.030 |
Why?
|
| Mass Screening | 2 | 2008 | 782 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2016 | 602 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 509 | 0.020 |
Why?
|
| Animals | 4 | 2017 | 34028 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2010 | 121 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2014 | 693 | 0.020 |
Why?
|
| Adolescent | 1 | 2008 | 19278 | 0.020 |
Why?
|
| Myocardium | 1 | 2014 | 997 | 0.020 |
Why?
|
| Regional Health Planning | 1 | 2008 | 6 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 443 | 0.020 |
Why?
|
| Contraindications | 1 | 2008 | 78 | 0.020 |
Why?
|
| Exercise | 1 | 2014 | 817 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1531 | 0.020 |
Why?
|
| Myocardial Revascularization | 1 | 2008 | 103 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2008 | 117 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 790 | 0.020 |
Why?
|
| Chest Pain | 1 | 2008 | 126 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 4345 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2008 | 356 | 0.020 |
Why?
|
| Patient Selection | 1 | 2008 | 695 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 2004 | 35 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2007 | 383 | 0.010 |
Why?
|
| Reference Standards | 1 | 2004 | 238 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 2092 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 2004 | 635 | 0.010 |
Why?
|
| Registries | 1 | 2004 | 1429 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1995 | 186 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2004 | 3071 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1995 | 490 | 0.010 |
Why?
|
| Critical Illness | 1 | 1995 | 602 | 0.010 |
Why?
|
| Survival Rate | 1 | 1995 | 2045 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1995 | 6147 | 0.000 |
Why?
|